0.3427

9.59% 0.03

Pre-market: .33 -0.0127 -3.71%

IGC Pharma Inc (IGC)

Overview News Price History Option Chain Discussions Forecast Stock Split

IGC Pharma Inc stock is traded at $0.3427, with a volume of 1.13M. It is up +9.59% in the last 24 hours and up +13.85% over the past month. India Globalization Capital, Inc. engages in the development and commercialization of cannabis-based therapies to treat Alzheimer's, pain, nausea, eating disorders, several end points of Parkinson's, and epilepsy in humans, dogs, and cats. The company operates through two segments, Legacy Infrastructure and Medical Cannabis Based Alternative Therapies. The Legacy Infrastructure segment trades in infrastructure commodities, such as steel and iron ore; and rents heavy equipment. The Medical Cannabis Based Alternative Therapies segment offers IGC-501 for indications of neuropathic pain; Serosapse for indications of Parkinson's and other central nervous system disorders; Caesafin for seizures in cats and dogs; and Natrinol for indications of cancer and AIDS induced nausea and vomiting, as well as Hyalolex for Alzheimer's patients. The company was founded in 2005 and is based in Bethesda, Maryland.

Previous Close:

$0.3127

Open:

$0.3282

24h Volume:

1.13M

Relative Volume:

2.73

Market Cap:

$22.90M

Revenue:

$1.22M

Net Income/Loss:

$-14.15M

P/E Ratio:

-1.3181

EPS:

-0.26

Net Cash Flow:

$-6.55M

1W Performance:

+22.35%

1M Performance:

+13.85%

6M Performance:

-3.76%

1Y Performance:

+5.41%

1-Day Range:

$0.315

$0.355

1-Week Range:

$0.2702

$0.355

52-Week Range:

$0.2608

$0.9099

IGC Pharma Inc Stock (IGC) Company Profile

Name

IGC Pharma Inc

Sector

Healthcare (1172)

Industry

Biotechnology (680)

Phone

301-983-0998

Address

4336 Montgomery Avenue, Bethesda, MD

Employee

Twitter

@IGCIR

Next Earnings Date

2025-02-18

Latest SEC Filings

IGC's Discussions on Twitter

Compare IGC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IGC IGC Pharma Inc	0.3427	22.90M	1.22M	-14.15M	-6.55M	-0.26
VRTX Vertex Pharmaceuticals Inc	495.42	127.22B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	689.50	75.38B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	591.45	35.94B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	242.43	31.38B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	249.84	26.84B	3.32B	-860.46M	-1.04B	-8.32

IGC Pharma Inc Stock (IGC) Latest News

Mar 12, 2025

IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q3 results. We believe more positive clinical data in 2025 to be strong catalysts for stock. Raising P/T to $4.25" - ACCESS Newswire

Mar 12, 2025

IGC Pharma Catches Analyst Attention: $4.25 Target Set as Clinical Milestones Approach - StockTitan

Mar 12, 2025

Mar 10, 2025

IGC Pharma Announces Equity Analyst Update by Alliance Global Partners (AGP) about the "Progressing Alzheimer-targeting efforts with notable Phase 2 CALMA interim results" - ACCESS Newswire

Mar 10, 2025

IGC Pharma Announces Equity Analyst Update by Alliance Global Partners (AGP) about the “Progressing Alzheimer-targeting efforts with notable Phase 2 CALMA interim results” - StockTitan

Mar 10, 2025

Mar 06, 2025